Catalent, Inc.

14 Schoolhouse Road,
Somerset, New Jersey 08873
United States,
(732) 537 6325

Catalent, Inc. is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent, Inc. was established in 2007 and is headquartered in Somerset, New Jersey.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (1.2/yr) # 1 2 - 2 1 1 7
vol $950M $950M
Sell (0.0/yr) # 1 - - - - - 1

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Sign-up to View
Sign-up to View

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Cook Group, Inc. (Cook Pharmica LLC)
$950M (2017-09-19)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

According to our data here at Mergr, Catalent has acquired 7 companies, including 6 in the last 5 years. It has also divested 1 asset.

Catalent’s largest acquisition to date was in 2017, when it acquired Cook Group for $950M. Catalent has acquired in 4 different US states, and 3 countries. The Company’s most targeted sectors include life science (43%) and medical products (43%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 409 life science companies that have made at least 1 acquisition, 15 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 30 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 6 platform acquisitions.

Join Mergr and gain access to Catalent’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.5K Private Equity Firms
  • 123K M&A Transactions
  • 132K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.